The GABA and GABA-Receptor System in Inflammation, Anti-Tumor Immune Responses, and COVID-19

炎症 免疫系统 2019年冠状病毒病(COVID-19) 严重急性呼吸综合征冠状病毒2型(SARS-CoV-2) 受体 2019-20冠状病毒爆发 γ-氨基丁酸受体 神经科学 生物 医学 免疫学 病毒学 内科学 疾病 传染病(医学专业) 爆发
作者
Jide Tian,Daniel L. Kaufman
出处
期刊:Biomedicines [Multidisciplinary Digital Publishing Institute]
卷期号:11 (2): 254-254 被引量:66
标识
DOI:10.3390/biomedicines11020254
摘要

GABA and GABAA-receptors (GABAA-Rs) play major roles in neurodevelopment and neurotransmission in the central nervous system (CNS). There has been a growing appreciation that GABAA-Rs are also present on most immune cells. Studies in the fields of autoimmune disease, cancer, parasitology, and virology have observed that GABA-R ligands have anti-inflammatory actions on T cells and antigen-presenting cells (APCs), while also enhancing regulatory T cell (Treg) responses and shifting APCs toward anti-inflammatory phenotypes. These actions have enabled GABAA-R ligands to ameliorate autoimmune diseases, such as type 1 diabetes (T1D), multiple sclerosis (MS), and rheumatoid arthritis, as well as type 2 diabetes (T2D)-associated inflammation in preclinical models. Conversely, antagonism of GABAA-R activity promotes the pro-inflammatory responses of T cells and APCs, enhancing anti-tumor responses and reducing tumor burden in models of solid tumors. Lung epithelial cells also express GABA-Rs, whose activation helps maintain fluid homeostasis and promote recovery from injury. The ability of GABAA-R agonists to limit both excessive immune responses and lung epithelial cell injury may underlie recent findings that GABAA-R agonists reduce the severity of disease in mice infected with highly lethal coronaviruses (SARS-CoV-2 and MHV-1). These observations suggest that GABAA-R agonists may provide off-the-shelf therapies for COVID-19 caused by new SARS-CoV-2 variants, as well as novel beta-coronaviruses, which evade vaccine-induced immune responses and antiviral medications. We review these findings and further advance the notions that (1) immune cells possess GABAA-Rs to limit inflammation in the CNS, and (2) this natural “braking system” on inflammatory responses may be pharmacologically engaged to slow the progression of autoimmune diseases, reduce the severity of COVID-19, and perhaps limit neuroinflammation associated with long COVID.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
qin202569发布了新的文献求助10
1秒前
CodeCraft的应助被Rony采纳,获得10
1秒前
东山完成签到,获得积分10
2秒前
一步一步完成签到,获得积分10
2秒前
晚晚发布了新的文献求助10
2秒前
2秒前
英俊的铭的应助被Lily采纳,获得10
2秒前
ccone完成签到,获得积分10
3秒前
ssiyyu发布了新的文献求助10
3秒前
3秒前
端庄威发布了新的文献求助10
3秒前
3秒前
cc完成签到,获得积分10
3秒前
jia发布了新的文献求助10
4秒前
100发布了新的文献求助10
4秒前
闪亮的季节完成签到,获得积分10
5秒前
xiaocao完成签到,获得积分10
5秒前
nothing完成签到,获得积分10
5秒前
6秒前
6秒前
Willing完成签到,获得积分10
7秒前
田様的应助被坚强孤容采纳,获得10
7秒前
8秒前
Nine完成签到,获得积分10
8秒前
nothing发布了新的文献求助10
8秒前
思源的应助被莫望采纳,获得10
8秒前
鲁万仇发布了新的文献求助10
8秒前
奔跑的应助被曹丹采纳,获得10
8秒前
9秒前
Maestro_S的应助被阿三发射点发采纳,获得10
9秒前
欢呼青易发布了新的文献求助10
9秒前
9秒前
9秒前
zzz完成签到,获得积分10
9秒前
jia完成签到,获得积分10
10秒前
JanaL发布了新的文献求助10
10秒前
yuyyuuyuy完成签到,获得积分10
10秒前
耍酷季节的应助被Gyqqqq采纳,获得50
10秒前
11秒前
顾矜的应助被qin202569采纳,获得10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183142
求助须知:如何正确求助?哪些是违规求助? 9572420
关于积分的说明 21825253
捐赠科研通 7779922
什么是DOI,文献DOI怎么找? 3433850
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480124